InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
27%
T+90 mean return
-9.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Doraiswamy Vinayak, Director. Officer active across 1 company, notably AtriCure, Inc.. Cumulatively, 16 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €1.4m. Activity tracked since 30 June 2021. The latest transaction was filed on 28 May 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations16 total
636 sharesCommon StockSEC:0001862458-26-000008:0
2,500 shares@ US$33.445.1% of flowCommon StockSEC:0001323885-25-000071:0
19,359 shares0Common StockSEC:0001323885-25-000023:0
707 shares@ US$19.350.9% of flowCommon StockSEC:0001323885-24-000097:0
19,294 shares0Common StockSEC:0001323885-24-000033:0
557 shares@ US$38.111.3% of flowCommon StockSEC:0001323885-23-000081:0
8,036 shares0Common StockSEC:0001323885-23-000026:0
4,983 shares@ US$45.9915.7% of flowCommon StockSEC:0001323885-22-000108:0
350 shares@ US$34.730.8% of flowCommon StockSEC:0001323885-22-000092:0
7,789 shares0Common StockSEC:0001323885-22-000027:0
24 shares@ US$59.100.1% of flowCommon StockSEC:0001209191-22-000387
24 shares@ US$59.100.0001% mcap0.1% of flowCommon StockSEC:0001209191-22-000387:0
7,672 shares@ US$83.1236.9% of flowCommon StockSEC:0001209191-21-046673
7,672 shares@ US$83.120.038% mcap48.4% of flowCommon StockSEC:0001209191-21-046673:0
428 shares@ US$45.720.0012% mcap1.5% of flowCommon StockSEC:0001209191-21-044939:0
428 shares@ US$45.721.1% of flowCommon StockSEC:0001209191-21-044939
16 of 16 declarations
About Doraiswamy Vinayak
Vinayak Doraiswamy is a Board Member at AtriCure, Inc. He is involved in overseeing the company's operations and strategic decision-making. With experience in the medical sector, he contributes to the strategic direction of AtriCure, which specializes in medical devices for treating heart diseases.
